Efficient Immortalization of Primary Human Keratinocytes
$172,426ZIAFY2022AINIH
National Institute Of Allergy And Infectious Diseases
Investigators
Linked publications & trials
Paper 38630576Paper 32791068Paper 30541782Paper 28968443Paper 24774536Paper 22966183Paper 22521418Paper 22189618Paper 20516646
Abstract
We have previously established a treatment that allows us to efficiently and conditionally immortalize primary human keratinocytes and other epithelial cells by culturing them in the presence of a ROCK inhibitor and with feeder fibroblasts. The technique is invaluable for the efficient procurement of cells from individuals with specific genetic and infectious diseases. In FY2022 we have cultured keratinocytes and fibroblasts from individuals at the NIH clinical center and extramural centers to assess the role of immunodeficiency in HPV infection, associated cancers and other genetic diseases.
View original record on NIH RePORTER →